KG, Terumo Corporation, Boston Scientific Corporation, Jotech GmbH, MicroPort Scientific Corporation, Hexacath, Meril Life Sciences Pvt Ltd, Cordis Corporation
, Abbott Laboratories, Cardionovum GmbH, and Cook Medical INC.
*The major key players of drug eluting stents market are Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys, Abbott Vascular Inc., AlviMedica Medical Technologies Inc., Amaranth Medical, Inc., HangZhou HuaAn Biotechnology Co.,Ltd, XTENT, Inc., CARDIONOVUM GmbH, Cordis Corporation
KYOTO MEDICAL PLANNING Co., Ltd.
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=3109 Few of the players involved in this market for Carotid Stenosis include Medtronic plc, Cordis Corporation
, Boston Scientific Corporation, Abbott, Cook Medical and InspireMD Inc.These are few companies present in the Carotid Stenosis market with emergence of new market players in future.
Partially responsible for J&J's windfall in 2003 resulted from Cordis Corporation
's (then a J&J business, now owned by Cardinal Health) April launch of a landmark treatment for coronary artery disease, and the first commercial device of its type--the Cypher drug-eluting stent, or DES for short.
The major players operating in this market are Abbott Vascular, SciTech, Boston Scientific Corporation, Medinol Ltd, iVascular SLU, Stentys SA, Elixir Medical Corporation, Inspire MD, Hexacath, Medtronic, Orbusneich, Andramed GmbH, Cordis Corporation
, Endocor GmbH, Eurocor GmbH, Comed B.V., MicroPort Scientific Corporation, Degania Silicone Ltd., Amaranth Medical, Inc., Terumo Corporation, Meril Life Sciences Pvt.
A 6F Multipurpose Guide Catheter (Cordis Corporation
, Florida, USA) was used as a guide.
Most recently, Dr Rogers has served as chief scientific officer and global head of Research and Development at Cordis Corporation
, a Johnson & Johnson company.
Also named as defendants in the suit are Bioheart chairman and founder of Cordis Corporation
, part of the Johnson & Johnson family of companies, has launched a new ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from infrarenal abdominal aortic aneurysms (AAA).
, the plaintiff brought an infringement action involving U.S.
has launched SABER PTA Dilatation Catheter (SABER Catheter) for the treatment of patients with Peripheral Arterial Disease (PAD).